Head-to-head · Cost-Efficiency Index
Ivy Rx vs Nu Image Medical
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Ivy Rx
Cost-first shoppers who want the lowest published entry price on a semaglutide microdose, for shoppers comfortable with unresolved pricing terms.
Visit Ivy RxNu Image Medical
Shoppers who want a marketplace floor price and don't need to know which pharmacy fills their order.
Visit Nu Image MedicalThe verdict
Ivy Rx and Nu Image Medical tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Ivy Rx (ranked #102, a hair above #106) — Cost-first shoppers who want the lowest published entry price on a semaglutide microdose, for shoppers comfortable with unresolved pricing terms. But Nu Image Medical is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Ivy Rx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Ivy Rx | Nu Image Medical |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $97/mo (microdose tier, promotional rate, compounded) | $99/mo (starting dose, compounded) |
| Tirzepatide / mo | $199/mo (brand Mounjaro, compounded) | $299/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $1,164 | $1,188 |
| Tirzepatide / yr (modeled) | $2,388 | $3,588 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Yes |
| Rank here | #102 | #106 |
Ivy Rx
69/100Where the value is
- Genuinely low entry price on the semaglutide microdose tier ($77/mo)
- HSA/FSA eligible with itemized receipts for reimbursement
- Legal entity is named (Ivy RX PLLC), which many competitors in this batch do not disclose
The tradeoffs
- The standard semaglutide price is shown as a struck-through discount ('$197 $97') with no label clarifying whether $97 is a standing rate or a temporary promo
- The advertised $199/mo tirzepatide rate requires a 12-month upfront lump-sum payment, not month-to-month billing, and a separate unexplained $1,399 vial price appears on the same page
Nu Image Medical
69/100Where the value is
- Publishes the identity of all four fulfillment pharmacies in its terms (Absolute Pharmacy LLC, Belmar Pharma Solutions, The Pharmacy Hub, TMC Acquisition dba Tailor Made Compounding) rather than staying anonymous about who compounds the medication
- LegitScript certified with a visible certificate number (453964)
- Both injectable and rapid-dissolve-tablet (RDT) formulations available for both semaglutide and tirzepatide
The tradeoffs
- The headline 'as low as' price is a floor across four different pharmacies with no guarantee which one fills a given order, so the number a specific patient actually pays can differ from the advertised figure
- No state coverage list is published anywhere — not the homepage, not the enrollment page, not the terms — only a generic 'where Services are available' clause
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.